Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

5.64
+0.06001.08%
Volume:13.74K
Turnover:78.16K
Market Cap:120.32M
PE:-1.14
High:5.80
Open:5.56
Low:5.56
Close:5.58
Loading ...
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Jan 26, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2023

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 23, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 16, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jun 07, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 07, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals